He has more than 20 years’ experience in leading businesses in B2B markets and setting up greenfield projects
Prior to this, Florian served as the Global Category Manager for DSM
She is Group Vice President, Corporate and Business Development of BioMarin Pharmaceutical Inc., a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare disorders
Melkko joined Tikkurila in 2019 and has served as CFO and a member of the management team
She has over 17 years of experience in Business Finance, Financial Strategy, P&L Management, Controllership and handling financial operations in multi-geographical businesses.
Jordan is the former President & Chief Operating Officer of DURA Automotive Systems, a tier one supplier of mechatronic control systems for hybrid/electric vehicle systems
Leadership appointments have happened for different units - Manufacturing, supply chain, transformation, procurement and technology
Snyder, who previously served as Chief Strategy Officer, joined the company in 2016 after serving as Vice President of Strategy and Vice President of Chlorovinyls at Axial
He is associated with the company over 25 years and presently acting as Non- Executive Director of the company
He is well versed with national and international exploration & production business and carries an extensive experience of offshore and onshore operations
He brings with him over two decades of deep insight, thought leadership and vast experience from the global textile chemical industry
Prior to this appointment, Bischoff served as Vice President for Product Management, Europe in the Performance Materials business division
The materials segment had revenues of €2.6 billion in 2020
Miedreich will succeed Marc Grynberg as CEO of the Group in the 4th quarter of this year
Lister has spent his entire career at Huntsman or its predecessors, starting in the polyurethanes division of Imperial Chemical Industries, which Huntsman acquired in 1999
Mark Newman, the company’s current Chief Operating Officer, will become President and Chief Executive Officer of Chemours, succeeding Mark Vergnano, who has served as President and Chief Executive Officer since the company’s founding in 2015
Stern will assume the position with effect from September 1, 2021 for a three-year period with an extension option for further two years subject to mutual consent
In his journey of 17+ years with UPL, he has served at various leadership positions across China, Taiwan, Middle East, Sri Lanka, Bangladesh, Turkey and European countries
Shanghvi is also the founder of Sun Pharmaceutical Industries Limited and Chairman of the Shantilal Shanghvi Foundation
Shende has an illustrious career in B2B sales, exports, and marketing spanning almost three decades
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg)
